The differential diagnosis of longitudinally extensive transverse myelitis (Q37888959)

24 August 2017

1 reference

title

The differential diagnosis of longitudinally extensive transverse myelitis (English)

1 reference

24 August 2017

0 references

J L Kitley

1

1 reference

24 August 2017

M I Leite

series ordinal

2

1 reference

24 August 2017

J S George

series ordinal

3

1 reference

24 August 2017

J A Palace

series ordinal

4

1 reference

24 August 2017

language of work or name

1 reference

13 June 2011

1 reference

Multiple Sclerosis Journal

24 August 2017

1 reference

24 August 2017

18

1 reference

24 August 2017

271-285

1 reference

24 August 2017

3

1 reference

Revised diagnostic criteria for neuromyelitis optica

24 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Isolated longitudinal myelitis: a report of six cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

The clinical course of idiopathic acute transverse myelitis in patients from Rio de Janeiro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

NMO-IgG and Devic's neuromyelitis optica: a French experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

NMO-IgG in the diagnosis of neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Neuromyelitis optica spectrum disorder as an initial presentation of primary Sjögren's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Sjogren's syndrome myelopathy: spinal cord involvement in Sjogren's syndrome might be a manifestation of neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Distinct subtypes of myelitis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Transverse myelitis affecting more than 4 spinal segments associated with systemic lupus erythematosus: clinical, immunological, and radiological characteristics of 22 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Clinical, radiologic, and therapeutic analysis of 14 patients with transverse myelitis associated with antiphospholipid syndrome: report of 4 cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Longitudinally extensive spinal cord lesion in a case of Neuro-Behçet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Acute disseminated encephalomyelitis-like manifestations in a patient with neuro-Behçet disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Neurosarcoidosis presenting as longitudinally extensive transverse myelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Spinal cord sarcoidosis: clinical and laboratory profile and outcome of 31 patients in a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Longitudinally extensive myelopathy in Caucasians: a West Australian study of 26 cases from the Perth Demyelinating Diseases Database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Pathologic and immunologic profiles of a limited form of neuromyelitis optica with myelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Brain abnormalities in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Brain magnetic resonance imaging findings in relapsing neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Clinical, CSF, and MRI findings in Devic's neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Oligoclonal bands in Devic's neuromyelitis optica and multiple sclerosis: differences in repeated cerebrospinal fluid examinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

The clinical course of neuromyelitis optica (Devic's syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Subacute syphilitic meningomyelitis with characteristic spinal MRI findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Acute transverse myelitis as a main manifestation of early stage II neuroborreliosis in two patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Abnormalities of spinal magnetic resonance images implicate clinical variability in human T-cell lymphotropic virus type I-associated myelopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

MRI findings of spinal visceral larva migrans of Toxocara canis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Longitudinally extensive transverse myelitis following vaccination with nasal attenuated novel influenza A(H1N1) vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Longitudinal myelitis associated with yellow fever vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Inflammatory transverse myelitis: evolving concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Devic's syndrome-like phenotype associated with thymoma and anti-CV2/CRMP5 antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Amphiphysin autoimmunity: paraneoplastic accompaniments

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Aquaporin-4 autoantibodies in a paraneoplastic context

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Childhood acute transverse myelitis: clinical profile, outcome, and association with antiganglioside antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Acute transverse myelitis and acute disseminated encephalomyelitis in childhood: spectrum or separate entities?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Idiopathic acute transverse myelitis in children: an analysis and discussion of MRI findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Magnetic resonance imaging features of the spinal cord in pediatric multiple sclerosis: a preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

CNS aquaporin-4 autoimmunity in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Spinal dural arteriovenous fistulas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Clinical and radiographic features of dural arteriovenous fistula, a treatable cause of myelopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Spinal cord ischemia: clinical and imaging patterns, pathogenesis, and outcomes in 27 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

MRI appearances in subacute combined degeneration of the spinal cord due to vitamin B12 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Copper deficiency myelopathy produces a clinical picture like subacute combined degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Neurotoxicity of radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Plasma exchange for acute attacks of CNS demyelination: Predictors of improvement at 6 months.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Neuromyelitis optica treatment: analysis of 36 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Sustained improvement of a girl affected with Devic's disease over 2 years of mycophenolate mofetil treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

An open label study of the effects of rituximab in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Efficacy and safety of mitoxantrone in patients with highly relapsing neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Immunosuppressive therapy is more effective than interferon in neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Relapsing neuromyelitis optica responsive to glatiramer acetate treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Glatiramer acetate treatment in Devic's neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

EFNS guidelines on diagnosis and management of neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Treatment of refractory neurosarcoidosis with Infliximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Preferential spinal central gray matter involvement in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

Clinical and laboratory features of neuromyelitis optica with oligoclonal IgG bands

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

MRI studies of spinal visceral larva migrans syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511406165

21 January 2018

Identifiers

DOI

10.1177/1352458511406165

1 reference

24 August 2017

1 reference